IVA Webinar | Developing a Standardised Integrative Nutraceutical for Splenic Hemangiosarcoma | Dr Matt Muir
December 3 @ 8:00 pm - 9:00 pm AEDT
Free - $50.00
Canine splenic hemangiosarcoma remains a major therapeutic challenge. This
presentation reviews conventional and emerging integrative evidence, then traces the
development of a standardised, multi-target nutraceutical, from clinical observations and
biological rationale through a clinical experience program toward prospective
investigation
Who should attend
Veterinarians
Learning outcomes
By the end of this presentation, participants will be able to:
-
Summarise the current evidence for conventional and integrative approaches to managing canine splenic haemangiosarcoma.
-
Describe the scientific rationale behind the development of a standardised, multi-target nutraceutical for dogs with haemangiosarcoma.
-
Discuss the progression from clinical observations and clinical experience programs to prospective investigation of novel therapeutic strategies.
Further details
Please ensure you are logged into the AVA Website to ensure correct pricing.
Our speakers
-
- Photograph
-
- Name
- Dr Matthew Muir
- Biography
Dr Matthew J Muir is an integrative veterinarian, Clinical Director of All Natural Vet Care, Chief Vet at Lyka and Technical Lead at VetFX. With 15 years of clinical experience, his work spans integrative medicine, nutrition, oncology support, nutraceuticals and
translational veterinary research. He has a particular interest in translating promising clinical observations and mechanistic evidence into practical, standardised interventions that can be evaluated scientifically. Matthew is also Chair of the Pet Longevity Institute’s
scientific advisory board and is involved with collaborative research in veterinary nutrition, healthy ageing and One Health.- Job title
- Clinical Director / Technical Veterinarian
Our sponsors
With thanks to Event Sponsors
-
- Logo
-
